Burgess Julie 4
4 · Design Therapeutics, Inc. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-01+75,000→ 75,000 totalExercise: $7.97Exp: 2033-01-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.